Effect of comorbid anxiety disorders on the Hypothalamic-Pituitary-Adrenal axis response to a social stressor in major depression

[1]  E. Young,et al.  Cortisol and Catecholamines in Posttraumatic Stress Disorder , 2004 .

[2]  E. Young,et al.  Cortisol and catecholamines in posttraumatic stress disorder: an epidemiologic community study. , 2004, Archives of general psychiatry.

[3]  E. Young,et al.  Salivary cortisol and posttraumatic stress disorder in a low-income community sample of women , 2004, Biological Psychiatry.

[4]  J. Thakore,et al.  HPA axis response to a psychological stressor in generalised social phobia , 2002, Psychoneuroendocrinology.

[5]  R. Yehuda.  Current status of cortisol findings in post-traumatic stress disorder. , 2002, The Psychiatric clinics of North America.

[6]  R. Yehuda,et al.  Cortisol levels in adult offspring of Holocaust survivors: relation to PTSD symptom severity in the parent and child , 2002, Psychoneuroendocrinology.

[7]  Steven M. Southwick,et al.  Increased pituitary and adrenal reactivity in premenopausal women with posttraumatic stress disorder , 2001, Biological Psychiatry.

[8]  M. Frye,et al.  Post-dexamethasone cortisol correlates with severity of depression before and during carbamazepine treatment in women but not men. , 2001, Acta psychiatrica Scandinavica.

[9]  I. Lucki,et al.  Abnormal salivary cortisol levels in social phobic patients in response to acute psychological but not physical stress , 2001, Biological Psychiatry.

[10]  Nichole E Carlson,et al.  Twenty-Four-Hour ACTH and Cortisol Pulsatility in Depressed Women , 2001, Neuropsychopharmacology.

[11]  S. Nolen-Hoeksema,et al.  Effect of ruminations on the saliva cortisol response to a social stressor , 2001, Psychoneuroendocrinology.

[12]  H. Akil,et al.  Hormonal Evidence for Altered Responsiveness to Social Stress in Major Depression , 2000, Neuropsychopharmacology.

[13]  R. Bonsall,et al.  Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood. , 2000, JAMA.

[14]  R. Yehuda,et al.  Low cortisol and risk for PTSD in adult offspring of holocaust survivors. , 2000, The American journal of psychiatry.

[15]  S. Bernasconi,et al.  Neuroendocrine Responses to Psychological Stress in Adolescents with Anxiety Disorder , 2000, Neuropsychobiology.

[16]  K. M. Yazıcı,et al.  Mixed anxiety–depressive disorder and major depressive disorder: comparison of the severity of illness and biological variables , 2000, Psychiatry Research.

[17]  Peter J. Munson,et al.  Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[18]  R. Kessler,et al.  Impairment in pure and comorbid generalized anxiety disorder and major depression at 12 months in two national surveys. , 1999, The American journal of psychiatry.

[19]  B. Kudielka,et al.  Impact of gender, menstrual cycle phase, and oral contraceptives on the activity of the hypothalamus-pituitary-adrenal axis. , 1999, Psychosomatic medicine.

[20]  D. M. Lyons,et al.  Salivary cortisol levels in socially phobic adolescent girls , 1999, Depression and anxiety.

[21]  E. Bosmans,et al.  Increased 24‐hour urinary cortisol excretion in patients with post‐traumatic stress disorder and patients with major depression, but not h patients with fibromyalgia , 1998, Acta psychiatrica Scandinavica.

[22]  P. Houck,et al.  Treatment outcomes for primary care patients with major depression and lifetime anxiety disorders. , 1996, The American journal of psychiatry.

[23]  S. Southwick,et al.  Noradrenergic mechanisms in stress and anxiety: I. preclinical studies , 1996, Synapse.

[24]  J. Abelson,et al.  Hypothalamic-pituitary-adrenal axis activity in panic disorder. 24-hour secretion of corticotropin and cortisol. , 1996, Archives of general psychiatry.

[25]  C. Coe,et al.  Abuse-Related Posttraumatic Stress Disorder: Evidence for Chronic Neuroendocrine Activation in Women , 1995, Psychosomatic medicine.

[26]  L. Grunhaus,et al.  Severe Depressive Disorders , 1994 .

[27]  H. Akil,et al.  Increased evening activation of the hypothalamic-pituitary-adrenal axis in depressed patients. , 1994, Archives of general psychiatry.

[28]  M. Tancer,et al.  Normal urinary free cortisol and postdexamethasone cortisol in social phobia: comparison to normal volunteers. , 1994, Journal of affective disorders.

[29]  R. Kessler,et al.  Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. , 1994, Archives of general psychiatry.

[30]  R. Bagby,et al.  Anxious and nonanxious depression. , 1993, The American journal of psychiatry.

[31]  J. Gorman,et al.  Responses of “generalized” and “discrete” social phobics during public speaking , 1993 .

[32]  C. Kirschbaum,et al.  The 'Trier Social Stress Test'--a tool for investigating psychobiological stress responses in a laboratory setting. , 1993, Neuropsychobiology.

[33]  G F Koob,et al.  The role of corticotropin-releasing factor in behavioural responses to stress. , 1993, Ciba Foundation symposium.

[34]  R. Bland.  Psychiatric Disorders in America: The Epidemiologic Catchment Area Study , 1992 .

[35]  W. Coryell,et al.  Anxiety syndromes as epiphenomena of primary major depression: outcome and familial psychopathology. , 1992, The American journal of psychiatry.

[36]  E. Eriksson,et al.  Higher postdexamethasone serum cortisol levels in agoraphobic than in nonagoraphobic panic disorder patients , 1991, Biological Psychiatry.

[37]  K. Krishnan,et al.  The Brief Social Phobia Scale. , 1991, The Journal of clinical psychiatry.

[38]  W. Coryell,et al.  The prognostic significance of HPA-axis disturbance in panic disorder: A three-year follow-up , 1991, Biological Psychiatry.

[39]  R. Lydiard.  Coexisting depression and anxiety: special diagnostic and treatment issues. , 1991, The Journal of clinical psychiatry.

[40]  Craig W. Berridge,et al.  Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses? , 1990, Brain Research Reviews.

[41]  S. Orr,et al.  Twenty-four hour urinary cortisol and catecholamine excretion in combat-related posttraumatic stress disorder , 1990, Biological Psychiatry.

[42]  J. Maser,et al.  Comorbidity of mood and anxiety disorders , 1990 .

[43]  P. Clayton,et al.  The comorbidity factor: establishing the primary diagnosis in patients with mixed symptoms of anxiety and depression. , 1990, The Journal of clinical psychiatry.

[44]  H. Calil,et al.  The dexamethasone suppression test: Its relationship to diagnoses, severity of depression and response to treatment , 1989, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[45]  E. Widmaier,et al.  Catecholaminergic modulation of corticotropin-releasing factor and adrenocorticotropin secretion. , 1989, Endocrine reviews.

[46]  O. Cameron,et al.  Endocrine and physiological changes during “spontaneous” panic attacks , 1987, Psychoneuroendocrinology.

[47]  P. Plotsky.  Facilitation of immunoreactive corticotropin-releasing factor secretion into the hypophysial-portal circulation after activation of catecholaminergic pathways or central norepinephrine injection. , 1987, Endocrinology.

[48]  R. Rubin,et al.  Neuroendocrine aspects of primary endogenous depression. I. Cortisol secretory dynamics in patients and matched controls. , 1987, Archives of general psychiatry.

[49]  G. Chrousos,et al.  Cerebrospinal fluid corticotropin-releasing hormone in depression: Relationship to noradrenergic function , 1987, Psychiatry Research.

[50]  Anand R. Kumar,et al.  Relationships of the dexamethasone suppression test to clinical severity and degree of melancholia , 1986, Biological Psychiatry.

[51]  B. Pfohl,et al.  Pituitary-adrenal axis rhythm disturbances in psychiatric depression. , 1985, Archives of general psychiatry.

[52]  G. Asnis,et al.  Cortisol secretion in endogenous depression. II. Time-related functions. , 1985, Archives of general psychiatry.

[53]  G. Asnis,et al.  Cortisol secretion in endogenous depression. I. Basal plasma levels. , 1985, Archives of general psychiatry.

[54]  P. Linkowski,et al.  The 24-hour profile of adrenocorticotropin and cortisol in major depressive illness. , 1985, The Journal of clinical endocrinology and metabolism.

[55]  D. Dunner,et al.  The DST in psychiatric outpatients with generalized anxiety disorder, panic disorder, or primary affective disorder. , 1985, The American journal of psychiatry.

[56]  D. Charney,et al.  Noradrenergic function and the mechanism of action of antianxiety treatment. II. The effect of long-term imipramine treatment. , 1985, Archives of general psychiatry.

[57]  D. Charney,et al.  Noradrenergic function and the mechanism of action of antianxiety treatment. I. The effect of long-term alprazolam treatment. , 1985, Archives of general psychiatry.

[58]  D. Charney,et al.  Neurobiological mechanisms in human anxiety evidence supporting central noradrenergic hyperactivity , 1983, Neuropharmacology.

[59]  J. Leckman.  The dexamethasone suppression test. , 1983, Journal of the American Academy of Child Psychiatry.

[60]  A. Schatzberg,et al.  Toward a biochemical classification of depressive disorders, VII: urinary free cortisol and urinary MHPG in depressions. , 1983, The American journal of psychiatry.

[61]  O. Cameron,et al.  The dexamethasone suppression test in panic disorder and agoraphobia. , 1982, The American journal of psychiatry.

[62]  A. Schatzberg,et al.  Toward a biochemical classification of depressive disorders , 1981, Psychopharmacology.

[63]  B. Carroll,et al.  A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility. , 1981, Archives of general psychiatry.

[64]  J. Mendels,et al.  Neuroendocrine regulation in depression. I. Limbic system-adrenocortical dysfunction. , 1976, Archives of general psychiatry.